Brief: Immunovant Announces Pricing Of $550 Million Common Stock Financing
11/12/2025 11:42
Dec 11 (Reuters) - Immunovant Inc IMVT.O: IMMUNOVANT ANNOUNCES PRICING OF $550 MILLION COMMON STOCK FINANCING IMMUNOVANT INC - OFFERS 26.2 MILLION SHARES AT $21.00 PER SHARE Source text: ID:nGNXb79BT Further company coverage: IMVT.O ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Immunovant
See all newsU.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies
Immunovant Q3 net loss smaller than expected
Brief: Immunovant Q3 Net Income USD -110.635 Million Vs. IBES Estimate USD -125.1 Million